SAB4300692
Anti-MELK antibody produced in rabbit
affinity isolated antibody
Synonym(s):
Anti-KIAA0175, Anti-hMELK, Anti-hPK38
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
4
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
~74 kDa
species reactivity
rat, mouse, human
concentration
1 mg/mL
technique(s)
western blot: 1:500-1:1000
isotype
IgG
immunogen sequence
(I-R-R-Q-R)
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... MELK(9833)
Looking for similar products? Visit Product Comparison Guide
General description
Maternal embryonic leucine zipper kinase (MELK) is a serine/threonine kinase that exists in bi-lobal conformation. Structurally, MELK comprises an N-terminal catalytic domain, ubiquitin-associated (UBA) domain, and a kinase domain. The MELK gene is mapped to human chromosome location 9p13.2.The MELK antibody detects endogenous levels of total MELK protein.
Phosphorylates ZNF622 and may contribute to its redirection to the nucleus. May be involved in the inhibition of spliceosome assembly during mitosis.
Immunogen
Peptide sequence around aa. 626-630 (I-R-R-Q-R), according to the protein NP_055606.1
Application
Anti-MELK antibody produced in rabbit has been used in western blotting at a dilution of 1:1000.
Biochem/physiol Actions
Maternal embryonic leucine zipper kinase (MELK) participates in cell cycle regulation by interacting with cell cycle proteins. It may have a role in malignant cell survival and cancer stem cell growth. An elevated expression of MELK is observed in triple-negative breast cancer, glioblastoma multiforme(GBM), and astrocytomas.
Features and Benefits
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Physical form
Solution in phosphate-buffered saline containing 0.02% sodium azide and 50% glycerol
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
低风险生物材料
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Krzysztof P Rembacz et al.
Archives of biochemistry and biophysics, 671, 1-7 (2019-05-21)
Maternal Embryonic Leucine Zipper Kinase (MELK) is overexpressed in various tumors which has been convincingly linked to tumor cell survival. As such, MELK became an interesting target for pharmacological intervention. In this study we present the crystal structure of MELK
Arnold Bolomsky et al.
Haematologica, 103(2), 325-335 (2017-11-11)
Treatment of high-risk patients is a major challenge in multiple myeloma. This is especially true for patients assigned to the gene expression profiling-defined proliferation subgroup. Although recent efforts have identified some key players of proliferative myeloma, genetic interactions and players
Marisa Simon et al.
PloS one, 12(2), e0172832-e0172832 (2017-02-25)
Triple-negative breast cancer (TNBC) is an aggressive, highly recurrent breast cancer subtype, affecting approximately one-fifth of all breast cancer patients. Subpopulations of treatment-resistant cancer stem cells within the tumors are considered to contribute to disease recurrence. A potential druggable target
Suely K N Marie et al.
International journal of cancer, 122(4), 807-815 (2007-10-26)
We have performed cDNA microarray analyses to identify gene expression differences between highly invasive glioblastoma multiforme (GBM) and typically benign pilocytic astrocytomas (PA). Despite the significant clinical and pathological differences between the 2 tumor types, only 63 genes were found
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service